Company Overview

Alexandria Real Estate Equities, Inc. is a publicly traded real estate investment trust (REIT) specializing in the ownership, operation, and development of collaborative life science, agtech, and technology campuses. The company operates within the life science real estate and specialized office segments, with properties designed to support research, development, and commercialization activities for biotechnology, pharmaceutical, academic, and technology-driven tenants. Its primary revenue driver is rental income from long-term leases, predominantly with investment‑grade or well‑capitalized tenants in regulated and research‑intensive industries.

Founded in 1994, the company was among the first REITs to focus exclusively on life science real estate, establishing a differentiated niche characterized by high barriers to entry and mission‑critical facilities. Over time, Alexandria expanded from a regional operator into a national platform through targeted development in innovation clusters, strategic capital partnerships, and long-standing relationships with leading life science companies and research institutions. Its strategy emphasizes clustering tenants to foster collaboration, which management positions as a competitive advantage relative to traditional office landlords.

Business Operations

Alexandria operates primarily through a single reportable business segment focused on life science real estate, conducted through its operating partnership, Alexandria Real Estate Equities, L.P. The portfolio consists of operating properties and an active development and redevelopment pipeline, generating revenue mainly from lease rentals, tenant recoveries, and development‑related activities. Properties are purpose‑built or highly specialized, incorporating advanced laboratory infrastructure, flexible office space, and campus‑style amenities tailored to scientific research needs.

Operations are almost entirely domestic within the United States, with no material international property holdings. In addition to direct property ownership, the company engages in selective partnerships and joint ventures to manage risk and access capital while retaining operational control. Alexandria also provides limited ancillary services tied to property management and campus operations, but these are not significant standalone revenue sources.

Strategic Position & Investments

The company’s strategic direction centers on deepening its presence in established and emerging life science clusters, maintaining a high‑quality tenant base, and funding growth through disciplined development and redevelopment projects. Alexandria consistently allocates capital toward on‑campus expansions, modernization of existing assets, and sustainability initiatives aligned with long‑term tenant demand. Its strategy prioritizes balance sheet strength and access to diverse capital sources to support cyclical resilience.

Beyond real estate, Alexandria maintains a long‑standing strategic investment platform that includes minority investments in life science and technology companies, often tenants or ecosystem participants within its campuses. These investments are positioned as strategic rather than core revenue drivers and are intended to strengthen relationships within the innovation ecosystem. Information on specific portfolio companies is periodically disclosed, but the financial contribution of these investments is not considered material relative to rental operations.

Geographic Footprint

Alexandria’s operations are concentrated in premier U.S. life science markets, with major clusters in Greater Boston/Cambridge, San Francisco Bay Area, San Diego, Seattle, New York City, Research Triangle (North Carolina), and Maryland. Corporate headquarters are located in Pasadena, California, reflecting the company’s historical roots and ongoing West Coast presence.

The company’s geographic strategy emphasizes markets with leading research universities, teaching hospitals, and sustained venture capital activity. While Alexandria does not maintain international properties, its U.S. campuses support tenants with global operations, giving the company indirect exposure to international life science and technology trends without direct overseas real estate risk.

Leadership & Governance

Alexandria was founded by Joel S. Marcus, who has played a central role in shaping its life science‑focused strategy and long‑term vision. Leadership emphasizes disciplined capital allocation, sector specialization, and long‑duration tenant relationships. Governance practices are aligned with public REIT standards, with oversight provided by an independent board and a management team with deep experience in real estate, finance, and life sciences.

Key executives include:

• Joel S. Marcus – Executive Chairman
• Peter M. Moglia – Chief Executive Officer
• Daniel J. Ryan – Chief Financial Officer
• Kathleen A. Shell – Chief Operating Officer

Executive roles and titles are based on recent public disclosures; any subsequent changes have not been independently verified from available public sources.